IL6 and COVID-19: Thus, several biomarkers that have been associated with clinical myocarditis were found to occur in a majority of COVID-19 patients without a history of CVD that are under 50 years of age including troponin T, CRP, IL-6, CK-MB, D-dimer and kappa and lambda immunoglobulin FLCs.